Trade Precigen Inc - PGEN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023318% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001096% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 20.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.57 |
| Open | 1.52 |
| 1-Year Change | 9.35% |
| Day's Range | 1.49 - 1.54 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 1.57 | -0.02 | -1.26% | 1.59 | 1.59 | 1.51 |
| Apr 23, 2025 | 1.59 | 0.04 | 2.58% | 1.55 | 1.62 | 1.55 |
| Apr 22, 2025 | 1.50 | 0.12 | 8.70% | 1.38 | 1.53 | 1.38 |
| Apr 21, 2025 | 1.35 | 0.01 | 0.75% | 1.34 | 1.43 | 1.34 |
| Apr 17, 2025 | 1.36 | 0.01 | 0.74% | 1.35 | 1.40 | 1.31 |
| Apr 16, 2025 | 1.34 | -0.06 | -4.29% | 1.40 | 1.41 | 1.33 |
| Apr 15, 2025 | 1.41 | 0.01 | 0.71% | 1.40 | 1.43 | 1.35 |
| Apr 14, 2025 | 1.37 | -0.06 | -4.20% | 1.43 | 1.46 | 1.35 |
| Apr 11, 2025 | 1.37 | 0.10 | 7.87% | 1.27 | 1.39 | 1.25 |
| Apr 10, 2025 | 1.25 | -0.04 | -3.10% | 1.29 | 1.32 | 1.23 |
| Apr 9, 2025 | 1.36 | 0.24 | 21.43% | 1.12 | 1.40 | 1.10 |
| Apr 8, 2025 | 1.12 | -0.23 | -17.04% | 1.35 | 1.37 | 1.12 |
| Apr 7, 2025 | 1.29 | 0.14 | 12.17% | 1.15 | 1.32 | 1.09 |
| Apr 4, 2025 | 1.21 | -0.09 | -6.92% | 1.30 | 1.30 | 1.19 |
| Apr 3, 2025 | 1.31 | -0.07 | -5.07% | 1.38 | 1.41 | 1.31 |
| Apr 2, 2025 | 1.45 | 0.05 | 3.57% | 1.40 | 1.48 | 1.37 |
| Apr 1, 2025 | 1.41 | 0.00 | 0.00% | 1.41 | 1.47 | 1.37 |
| Mar 31, 2025 | 1.46 | -0.05 | -3.31% | 1.51 | 1.51 | 1.39 |
| Mar 28, 2025 | 1.56 | -0.05 | -3.11% | 1.61 | 1.61 | 1.55 |
| Mar 27, 2025 | 1.60 | 0.02 | 1.27% | 1.58 | 1.61 | 1.52 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 20
- 100
- 500
- 1000
- 10000
Precigen Inc
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch inducible gene switch that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with ZIOPHARM Oncology, Inc.; Ares Trading S.A.; Oragenics, Inc.; Intrexon T1D Partners, LLC; Intrexon Energy Partners, LLC; Intrexon Energy Partners II, LLC; Fibrocell Science, Inc.; OvaXon, LLC; S & I Ophthalmic, LLC; Harvest start-up entities; and Surterra Holdings, Inc. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com